September 1st is World Chronic Lymphocytic Leukaemia (CLL) Day, the most common leukaemia in adults. Most patients with CLL respond well to treatment1
The model was created by injecting tumour cells from a patient into a mouse. This makes it possible to imitate the leukaemia’s transformation into a1
There are still many questions surrounding lymphoma, its differences with leukemia and, above all, its treatment.
On 18 November, the Spanish Cancer Research Association (ASEICA) presented the awards, with which it recognises the efforts of Spanish researchers in1
This discovery changes the view of the progression of leukaemia, opens the door to early diagnosis, and offers new treatment strategies.
An international study, published in Nature Genetics, identifies more than 100 new genes involved in the disease and defines new groups of patients w1
The partnership aims to improve current characterization and research practices of this disease.
A study carried out at Hospital Clínic of Barcelona analysed the outcomes of patients with autoimmune disease and COVID-19 infection who were admitte1
A consortium of researchers from the Cancer Research Center of Ontario and the Hospital for Sick Children of Toronto, the Hospital Clínic-IDIBAPS of1
Researchers at IDIBAPS have published a study in Nature Communications in which they have deciphered the molecular basis of the genetic predispositio1
